Prognostic impact of advanced lung cancer inflammation index and tumor load index in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

Key Points

• Low lung cancer inflammation index combined with high tumor load identifies aggressive esophageal squamous cell carcinoma cases, leading to poor survival.
• The study indicates that this combined index can help tailor risk-adapted treatment strategies for better outcomes in esophageal cancer patients.
• Integration of the lung cancer inflammation index and tumor load index shows strong prognostic value for patient management after neoadjuvant immunochemotherapy.
• This analysis highlights the need for personalized treatment plans based on individual tumor characteristics for managing esophageal squamous cell carcinoma.